CFM
PCRX icon

Cornerstone Financial Management’s Pacira BioSciences PCRX Stock Holding History

Cornerstone Financial Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Hold
51
– – ﹤0.01% 988
2026
Q1 		$1.15K Hold
51
– – ﹤0.01% 917
2025
Q4 		$1.32K Buy
+51
New +$1.21K ﹤0.01% 828

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Financial Management's PCRX Position: Q2 2026 in Review

Cornerstone Financial Management held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 51 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Cornerstone Financial Management first reported a position in PCRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.32K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Cornerstone Financial Management held 51 shares of Pacira BioSciences worth $1.29K as of Q2 2026.
  • Cornerstone Financial Management left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #988 holding.
  • Cornerstone Financial Management first reported a position in Pacira BioSciences in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's Pacira BioSciences position peaked at $1.32K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.